1. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
   Remy Thomas et al, 2020, Cancer Immunology, Immunotherapy CrossRef
2. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
   Dawn Sijin Nin et al, 2023, Cells CrossRef
3. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
   Adviti Naik et al, 2020, Frontiers in Oncology CrossRef
4. Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma
   Yibo Hua et al, 2017, Tumor Biology CrossRef
5. Roles of cancer/testis antigens (CTAs) in breast cancer
   Yongfei Li et al, 2017, Cancer Letters CrossRef
6. Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
   Adviti Naik et al, 2022, Molecular Oncology CrossRef
7. The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in vitro highlights a new role for lactate
   Maitham Khajah et al, 2023, Molecular Medicine Reports CrossRef
8. Revisiting lactate dynamics in cancer—a metabolic expertise or an alternative attempt to survive?
   Cindy Mendes et al, 2020, Journal of Molecular Medicine CrossRef
9. Correlation between promoter methylation of the LDH‑C4 gene and DNMT expression in breast cancer and their prognostic significance
   Jiandong Zhang et al, 2021, Oncology Letters CrossRef
10. Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
    Nuria Gómez-Cebrián et al, 2019, Metabolites CrossRef
11. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients
    Shengnan Wang et al, 2024, BMC Cancer CrossRef
12. Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro
    Maitham A. Khajah et al, 2021, Frontiers in Pharmacology CrossRef
13. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer
    Zhaolei Cui et al, 2020, Clinica Chimica Acta CrossRef
14. Identification of human LDHC4 as a potential target for anticancer drug discovery
    Hong Tan et al, 2022, Acta Pharmaceutica Sinica B CrossRef
15. The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling
    Chuan-Hua Zhan et al, 2022, Bioengineered CrossRef
16. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas
    Anna Mária Tőkés et al, 2022, Frontiers in Oncology CrossRef
17. TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy
    Jenni Fleischauer et al, 2023, Cells CrossRef
18. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma
    Liangyuan Chen et al, 2021, Experimental Cell Research CrossRef
19. Oxamate targeting aggressive cancers with special emphasis to brain tumors
    Meric A. Altinoz et al, 2022, Biomedicine & Pharmacotherapy CrossRef
20. Patent Highlights December 2021–January 2022
    Hermann AM Mucke, 2022, Pharmaceutical Patent Analyst CrossRef
21. The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival
    Adviti Naik et al, 2024, Cancers CrossRef
22. Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
    Deepshikha Mishra et al, 2019, Cancers CrossRef
23. Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders
    Jacinta Serpa, 2020, Tumor Microenvironment CrossRef
24. Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity
    Jinzhi Huang et al, 2021, Aging CrossRef
25. Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma
    Wei Peng et al, 2022, Frontiers in Oncology CrossRef